Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine Monotherapy or Combination with Adefovir in HBV-Associated HCC
NCT01263002Phase 4Completed
- Sponsor
- Bukwang Pharmaceutical
- Start
- Jun 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clevudine in hepatitis B (HBV), sponsored by Bukwang Pharmaceutical. Started Jun 2010; status: completed.
02
Drugs
clevudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01263002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263002.